Nonsteroidal anti-inflammatory drug use is a risk factor for early Type II endoleak after endovascular abdominal aortic repair

Yutaka Matsubara; Kentaro Inoue; Kazuki Mori; Masato Morita; Satoshi Takebayashi; Masazumi Kume

doi:10.1177/1708538119866603

Nonsteroidal anti-inflammatory drug use is a risk factor for early Type II endoleak after endovascular abdominal aortic repair

Vascular. 2020 Feb;28(1):53-58. doi: 10.1177/1708538119866603. Epub 2019 Jul 25.

Authors

Yutaka Matsubara¹, Kentaro Inoue¹, Kazuki Mori¹, Masato Morita¹, Satoshi Takebayashi¹, Masazumi Kume¹

Affiliation

¹ Department of Cardiovascular Surgery, Beppu Medical Center, Oita, Japan.

PMID: 31342868
DOI: 10.1177/1708538119866603

No abstract available

Keywords: Endovascular aneurism repair; Type II endoleak; abdominal aortic aneurysm; nonsteroidal anti-inflammatory drugs; postimplantation syndrome.

MeSH terms

Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Aortic Aneurysm, Abdominal / diagnostic imaging
Aortic Aneurysm, Abdominal / surgery*
Blood Vessel Prosthesis Implantation / adverse effects*
Drug Administration Schedule
Endoleak / diagnosis
Endoleak / etiology*
Endovascular Procedures / adverse effects*
Female
Humans
Japan
Male
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome

Substances

Anti-Inflammatory Agents, Non-Steroidal